Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Human somatic mutation assays as biomarkers of carcinogenesis

Journal Article · · Environmental Health Perspectives; (United States)
DOI:https://doi.org/10.2307/3431307· OSTI ID:6093984
;  [1];  [2]
  1. Univ. of California, Berkeley (United States)
  2. California Dept. of Health Services, Berkeley (United States)

This paper describes four assays that detect somatic gene mutations in humans: the hypoxanthine-guanine phosphoribosyl transferase assay, the glycophorin A assay, the HLA-A assay, and the sickle cell hemoglobin assay. Somatic gene mutations can be considered a biomarker of carcinogenesis, and assays for somatic mutation may assist epidemiologists in studies that attempt to identify factors associated with increased risks of cancer. Practical aspects of the use of these assays are discussed.

OSTI ID:
6093984
Journal Information:
Environmental Health Perspectives; (United States), Journal Name: Environmental Health Perspectives; (United States) Vol. 94; ISSN 0091-6765; ISSN EVHPA
Country of Publication:
United States
Language:
English